Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P37231|||Q15179 Gene ID: 5468.0 Gene Symbol: PPARG Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16033271 |
|||
Target ID: Q92633 Gene ID: 1902.0 Gene Symbol: LPAR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16033271 |
10.0 µM [IC50] | ||
Target ID: Q9HBW0 Gene ID: 9170.0 Gene Symbol: LPAR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16033271 |
5.5 µM [IC50] | ||
Target ID: Q9UBY5 Gene ID: 23566.0 Gene Symbol: LPAR3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16033271 |
3.1 µM [IC50] |
| Substance Class |
Mixture
Created
by
admin
on
Edited
Wed Apr 02 05:00:32 GMT 2025
by
admin
on
Wed Apr 02 05:00:32 GMT 2025
|
| Record UNII |
1RXS4UE564
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QB01AD02
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
||
|
FDA ORPHAN DRUG |
163502
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
||
|
FDA ORPHAN DRUG |
331410
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
||
|
WHO-ATC |
B01AD02
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
||
|
FDA ORPHAN DRUG |
431414
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
||
|
WHO-ATC |
S01XA13
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
||
|
WHO-VATC |
QS01XA13
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
||
|
NCI_THESAURUS |
C29750
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Alteplase
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
5141
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201593
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
1RXS4UE564
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
SUB32223
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
Alteplase
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
SUB126952
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
8410
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | RxNorm | ||
|
DB00009
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
SUB05378MIG
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
100000089921
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
1RXS4UE564
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
C39607
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
X-35
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
4985
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
5975
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
D010959
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | |||
|
m10894
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
105857-23-6
Created by
admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
|
PRIMARY |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUBSTRATE->ENZYME | |||
|
TARGET->ENZYME | |||
|
|
SUBSTRATE->ENZYME |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|